1. Ahmad G, Brown J, Duffy JM, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD000099.2.
  2. Albertini DF, Rider V. Patterns of intercellular connectivity in the mammalian cumulus-oocyte complex. Microsc Res Tech. 1994;27:125-33.
  3. Azuma C, Saji F, Kimura T, et al. Steroid hormones induce macrophage colony-stimulating factor (MCSF) and MCSF receptor mRNAs in the human endometrium. J Mol Endocrinol. 1990 Oct;5(2):103-8.3.
  4. Bahceci M, Ulug U, Turan E, Akman MA. Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor-1 (IGF-1) and epidermal growth factor (EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist. Eur J Obstet Gynecol Reprod Biol. 2007 Jan;130(1):93-8.
  5. Balasch J, Fabregues F, Penarrubia J, et al. Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH. Hum Reprod 2006 Jul; 21(7):1884–1893.
  6. Barad D, Gleicher N . Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum. Reprod. 2006 Nov;21(11):2845–9.
  7. Barad DH, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil. Steril. 2005.Sep;84(3):756.
  8. Barritt JA, Brenner CA, Malter HE, Cohen J. Mitochondria in human offspring derived from ooplasmic transplantation Hum Reprod. 2001;16:513-6.
  9. Bartmann AK, Romão GS, Ramos Eda S, Ferriani RA. Why do older women have poor implantation rates? A possible role of the mitochondria. J Assist Reprod Genet. 2004;21:79-83
  10. Ben-Meir A, Burstein E, Borrego-Alvarez A, Chong J, Wong E, Yavorska T, Naranian T, Chi M, Wang Y, Bentov Y, Alexis J, Meriano J, Sung HK, Gasser DL, Moley KH, Hekimi S, Casper RF, Jurisicova A. Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. Aging Cell 2015;14:887-95.
  11. Ben-Meir A, Yahalomi S, Moshe B, Shufaro Y, Reubinoff B, Saada A (2015b) Coenzyme Q-dependent mitochondrial respiratory chain activity in granulosa cells is reduced with aging. Fertil Steril 104: 724-727
  12. Bentov Y, Esfandiari N, Burstein E, Casper RF. The use of mitochondrial nutrients to improve the outcome of infertility treatment in older patients. Fertil Steril. 2010 Jan;93(1):272-5.
  13. Bentov Y, Hannam T, Jurisicova A, Esfandiari N, Casper RF. (2014) Coenzyme Q10 supplementation and oocyte aneuploidy in women undergoing IVF-ICSI treatment. Clinical Medicine Insights: Reproductive Health. Jun; 8:31-36.
  14. Bhatnagar P, Papaioannou VE and Biggers JD. (1995) CSF-1 and mouse preimplantation development in vitro. Development 121, 1333–1339.
  15. Bosdou JK, Venetis CA, Kolibianakis EM, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2012 Mar;18(2):127-45.
  16. Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum Reprod Update. 2003 Nov-Dec;9(6):515-22.
  17. Brann DW, Mahesh VB. The aging reproductive neuroendocrine axis. Steroids. 2005 Apr;70(4):273-83.
  18. Brannstrom M and Norman RJ (1993) Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 8,1762–1775.
  19. Brannstrom M, Norman RJ, Seamark RF and Robertson SA. Rat ovary produces cytokines during ovulation. Hum Reprod. 1993 Oct;8(10):1762-75.
  20. Brodin T, Bergh T, Berglund L, Hadziosmanovic N, Holte J. Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization. Fertil Steril. 2008 Nov;90(5):1656-61.
  21. Cai J, Lou HY, Dong MY, et al. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells. Fertil Steril. 2007 Jun;87(6):1350-6.
  22. Calhoun DA, Donnelly WH Jr, Du Y, Dame JB, Li Y and Christensen RD (1999) Distribution of granulocyte colony-stimulating factor (G-CSF) and G-CSF-receptor mRNA and protein in the human fetus. Pediatr Res. 1999 Sep;46(3):333-8.
  23. Check JH, Check ML, Katsoff D. Three pregnancies despite elevated serum FSH and advanced age: case report. Hum. Reprod. 2000 Aug;15 (8): 1709–12.
  24. Check JH. Mild ovarian stimulation. J. Assist. Reprod. Genet. 2007 Dec;24(12):621–7.
  25. Check JH. Pharmacological options in resistant ovary syndrome and premature ovarian failure. Clin Exp Obstet Gynecol 2006;33(2):71–7.
  26. Check ML, Check JH, Choe JK, Berger GS. Successful pregnancy in a 42-year-old woman with imminent ovarian failure following ovulation induction with ethinyl estradiol without gonadotropins and in vitro fertilization. Clin Exp Obstet Gynecol 2002;29(1): 11–4.
  27. Check ML, Check JH, Kaplan H. Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review. Clin Exp Obstet Gynecol 2004;31(4):299–301.
  28. Cohen J, Scott R, Alikani M, Schimmel T, Munné S, Levron J, Wu L, Brenner C, Warner C, Willadsen S. Ooplasmic transfer in mature human oocytes. Mol Hum Reprod 1998;4:269-280.
  29. Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril. 1995 Oct;64(4):740-5.
  30. Dalton CM, Szabadkai G, Carroll J. Measurement of ATP in single oocytes: impact of maturation and cumulus cells on levels and consumption. J Cell Physiol. 2014;229:353-61.
  31. Davar R, Oskouian H, Ahmadi S, Firouzabadi RD. GnRH antagonist/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization. Taiwan J Obstet Gynecol. 2010 Sep;49(3):297-301.
  32. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010 Sep 11;376(9744):911-2.16.
  33. de Ziegler D, Streuli I, Meldrum DR, Chapron C. The value of growth hormone supplements in ART for poor ovarian responders. Fertil Steril. 2011 Nov;96(5):1069-76.
  34. Demirol A, Gurgan T. Comparison of microdose flare-up and antagonist multiple-dose protocols for poor-responder patients: a randomized study. Fertil Steril. 2009 Aug;92(2):481-5.
  35. Dirnfeld M, Fruchter O, Yshai D, Lissak A, Ahdut A, Abramovici H. Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization. Fertil Steril. 1999 Sep;72(3):406-11.
  36. Dragojević-Dikić S, Rakić S, Nikolić B, Popovac S. Hormone replacement therapy and successful pregnancy in a patient with premature ovarian failure. Gynecol. Endocrinol. 2009 Dec;25(12):769–72.
  37. Duan JS. Production of granulocyte colony stimulating factor in decidual tissue and its significance in pregnancy. Osaka City Med J. 1990 Nov;36(2):81-97.
  38. Duffy JM, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD000099.
  39. El Shourbagy SH, Spikings EC, Freitas M, St John JC. Mitochondria directly influence fertilisation outcome in the pig. Reproduction. 2006;131:233-45.
  40. Erickson GF and Danforth DR. Ovarian control of follicle development. Am J Obstet Gynecol. 1995 Feb;172(2 Pt 2):736-47.
  41. Erol B, Bozlu M, Hanci V, Tokgoz H, Bektas S, Mungan G. Coenzyme Q10 treatment reduces lipid peroxidation, inducible and endothelial nitric oxide synthases, and germ cell-specific apoptosis in a rat model of testicular ischemia/reperfusion injury. Fertil Steril. 2010 Jan;93(1):280-2.
  42. Fabregues F, Penarrubia J, Creus M, et al. Trans dermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial. Hum Reprod. 2009 Feb;24(2):349-59.
  43. Fakih MH, Shmoury ME, Szeptycki J, dela Cruz DB, Lux C, Verjee S, Burgess CM, Cohn GM, Casper RF. The AUGMENTSM treatment: Physician reported outcomes of the initial global patient experience. JFIV Reprod Med Genet 2015;3:154.
  44. Ferraretti AP, La Marca A, Fauser BC, et al. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011 Jul;26(7):1616-24.
  45. Fisch JD, Keskintepe L, Sher G. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure. Fertil. Steril. 2008 Feb;89(2):342–7.
  46. Frattarelli JL, Peterson EH. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril. 2004 Jun;81(6):1713-4.
  47. Garcia-Velasco JA, Somigliana E. Management of endometriomas in women requiring IVF: to touch or not to touch. Hum Reprod. 2009 Mar;24(3):496-501.
  48. Garrido N, Navarro J, Remohi J, Simon C and Pellicer A. Follicular hormonal environment and embryo quality in women with endometriosis. Hum Reprod Update. 2000 Jan-Feb;6(1):67-74.
  49. Gleicher N, Ryan E, Weghofer A, Blanco-Mejia S, Barad DH. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod. Biol. Endocrinol. 2009 Oct 7;7:108.
  50. Gleicher N, Weghofer A, Oktay K, Barad D. Relevance of triple CGG repeats in the FMR1 gene to ovarian reserve. Reprod Biomed Online. 2009 Sep;19(3):385-90.
  51. González-Fernández R1, Peña Ó, Hernández J, Martín-Vasallo P, Palumbo A, Ávila J. Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways. Fertil Steril. 2011 Jun;95(7):2373-8.
  52. Grossman LI, Shoubridge EA. Mitochondrial genetics and human disease. BioEssays 1996;18:983-991.
  53. Harper K, Proctor M, Hughes E. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2003;(3):CD000099.
  54. Hugues JN, Durnerin IC. Impact of androgens on fertility - physiological, clinical and therapeutic aspects. Reprod Biomed Online. 2005 Nov;11(5):570–580.
  55. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germ-line stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145-150.
  56. Kahraman K, Berker B, Atabekoglu CS, et al. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection–embryo transfer cycle. Fertil Steril. 2009 Jun;91(6):2437-44.
  57. Kalmbach KH, Antunes DM, Kohlrausch F, Keefe DL. Telomeres and Female Reproductive Aging. Semin Reprod Med. 2015;33:389-95.
  58. Kato K, Takehara Y, Segawa T, et al. Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort. Reprod Biol Endocrinol. 2012 Apr 27;10:35.
  59. Katsoff B, Check JH. Successful pregnancy in a 45-year-old woman with elevated day 3 serum follicle stimulating hormone and a short follicular phase. Clin Exp Obstet Gynecol 2005;32(2):97–8.
  60. Kawamura K, Cheng Y, Suzuki N, Deguchi M, Sato Y, Takae S, Ho CH, Kawamura N, Tamura M, Hashimoto S, Sugishita Y, Morimoto Y, Hosoi Y, Yoshioka N, Ishizuka B, Hsueh AJ. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17474-9.
  61. Kim CH, Howles CM, Lee HA. The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders. Fertil Steril. 2011 Feb;95(2):679-83.
  62. Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009 Nov-Dec; 15(6):613-22.
  63. Kucuk T, Kozinoglu H, Kaba A. Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial. J Assist Reprod Genet. 2008 Apr; 25(4):123-7.
  64. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009 Mar;91(3):749-66.
  65. Li J, Kawamura K, Cheng Y, Liu S, Klein C, Liu S, Duan EK, Hsueh AJ. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10280-4.
  66. Liu X, Fernandes R, Gertsenstein M, Perumalsamy A, Lai I, Chi M, Moley KH, Greenblatt E, Jurisica I, Casper RF, Sun Y, Jurisicova A. (2011) Automated microinjection of recombinant BCL-X into mouse zygotes enhances embryo development. PLoS One. 6(7):e21687.
  67. Loutradis D, Drakakis P, Vomvolaki E, Antsaklis A. Different ovarian stimulation protocols for women with diminished ovarian reserve. J. Assist. Reprod. Genet. 2007 Dec;24(12):597–611.
  68. Mamas L, Mamas E. Premature ovarian failure and dehydroepiandrosterone. Fertil. Steril.2009 Feb;91(2):644–6.
  69. May-Panloup, P., Chretien, M., Malthiery, Y., Reynier, P., 2007. Mitochondrial DNA in the oocyte and the developing embryo. Curr. Top. Dev. Biol. 2007;77:51–83.
  70. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas. 1992 Jan;14(2):103-15.
  71. Mendoza C, Ruiz-Requena E, Ortega E, et al. Follicular fluid markers of oocyte developmental potential. Hum Reprod. 2002 Apr;17(4):1017-22.
  72. Midgette AS, Baron JA. Cigarette smoking and the risk of natural menopause. Epidemiology. 1990 Nov;1(6):474-80.
  73. Muggleton-Harris A, Whittingham, DG, Wilson L. Cytoplasmic control of preimplantation development in vitro in the mouse. Nature 1982;299:460-462.
  74. Nargund G, Cheng WC, Parsons J. The impact of ovarian cystectomy on ovarian response to stimulation during in-vitro fertilization cycles. Hum Reprod. 1996 Jan;11(1):81-3.
  75. Oktay K, Baltaci V, Sonmezer M, Turan V, Unsal E, Baltaci A, Aktuna S, Moy F. Oogonial Precursor Cell-Derived Autologous Mitochondria Injection to I
  76. Oktem O, Oktay K. Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function. Cancer. 2007 Nov 15;110(10):2222-9.
  77. Oudendijk JF, Yarde F, Eijkemans MJ, Broekmans FJ, Broer SL.The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update. 2012 Jan-Feb;18(1):1-11.
  78. Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008 Jun;89(6):1694-701.
  79. Perumalsamy, A, Fernandes, R, Lai, I, Detmar, J, Varmuza, S, Casper, RF, Jurisicova, A. (2010) Developmental consequences of alternative Bcl-x splicing during preimplantation embryo development. FEBS J. [Feb. 3]; 277:1219-1233.
  80. Qin Y, Zhao Z, Sun M, Geng L, Che L, Chen ZJ. Association of basal serum testosterone levels with ovarian response and in vitro fertilization outcome. Reprod Biol Endocrinol. 2011 Jan 20;9:9.
  81. Salmassi A, Schmutzler AG, Schaefer S, et al. Is granulocyte colony-stimulating factor level predictive for human IVF outcome? Hum Reprod. 2005 Sep; 20(9):2434-40.
  82. Santos TA, El Shourbagy S, St John JC. Mitochondrial content reflects oocyte variability and fertilization outcome. Fertil Steril. 2006 Mar;85(3):584-91.
  83. Sauer MV, Paulson RJ, Lobo RA. Pregnancy in women 50 or more years of age: outcomesof 22 consecutively established pregnancies from oocyte donation. Fertil Steril.1995 Jul;64(1): 111–5.
  84. Schmidt DW, Bremner T, Orris JJ, Maier DB, Benadiva CA, Nulsen JC. A ran- domized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders. Fertil Steril. 2005 May;83(5):1568-71.
  85. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000 Nov-Dec;30(6):298-30.
  86. Shoubridge EA. Mitochondrial DNA segregation in the developing embryo. Human Reprod 2000;15 (Suppl. 2):229-234
  87. Snieder H, MacGregor AJ, Spector TD. Genes control the cessation of a woman›s reproductive life: a twin study of hysterectomy and age at menopause. J Clin Endocrinol Metab.1998 Jun;83(6):1875-80.
  88. Song Y, Zhang L, Chen S, Ni D, Li B, Zhou Y, Lei B, Wang T. Cytoplasm transfer in mature rabbit oocytes. Conf Proc IEEE Eng Med Bio Soc. 2014;2014:2903-6.
  89. Souza AFM, Giugliani R. Doenças Mitocondriais. In: Carakushanski E. Doenças Genéticas em Pediatria. Ed. Guanabara Koogan, RJ, 2001. Pp: 189-195.
  90. St. John JC. Ooplasm donation in humans: the need to investigate the transmission of mitochondrial DNA following cytoplasmic transfer. Hum Reprod 2002;17: 1954-1958.
  91. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003 Jan-Feb;9(1):61-76.
  92. Tartagni M, Cicinelli E, De Pergola G, De Salvia MA, Lavopa C, Loverro G. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with prematureovarian failure: a randomized, placebo-controlled trial. Fertil. Steril. 2007 Apr;87 (4): 858–61.
  93. Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet. 2009 Apr;105(1):43-5.
  94. Tesarik J, Hazout A, Mendoza C. Improvement of delivery and live birth rates after ICSI in women aged >40 years by ovarian co-stimulation with growth hormone. Hum Reprod. 2005 Sep; 20(9):2536-41.
  95. Torgerson DJ, Thomas RE, Campbell MK, Reid DM. Alcohol consumption and age of maternal menopause are associated with menopause onset. Maturitas. 1997 Jan;26(1):21-5.
  96. Treloar SA, Do KA, Martin NG. Genetic influences on the age at menopause. Lancet. 1998 Oct 3;352(9134):1084-5.
  97. Turi A, Giannubilo SR, Brugè F, Principi F, Battistoni S, Santoni F, Tranquilli AL, Littarru G, Tiano L. Coenzyme Q10 content in follicular fluid and its relationship with oocyte fertilization and embryo grading . Arch Gynecol Obstet. 2012 Apr;285(4):1173-6.
  98. Van Blerkom J, Davis P, Thalhammer V. Regulation of mitochondrial polarity in mouse and human oocytes: the influence of cumulus derived nitric oxide. Mol Hum Reprod 2008;14:431–444.
  99. Van Blerkom J, Davis PW, Lee J. ATP content of human oocytes and developmental potential and outcome after in-vitro fertilization and embryo transfer. Hum Reprod. 1995;10:415-24.
  100. Van Blerkom J, Sinclair J, Davis P. Mitochondrial transfer between oocytes: potential applications of mitochondrial donation and the issue of heteroplasmy. Human Reproduction 1998;13: 2857-2868.
  101. Van Blerkom J. Mitochondrial function in the human oocyte and embryo and their role in developmental competence. Mitochondrion 2011;11:797–813
  102. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest. 1998 Jun 15;101(12):2622-9.
  103. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab. 1999 Aug;84(8):2951-6.
  104. Weil SJ, Vendola K, Zhou J, et al. Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations.J Clin Endocrinol Metab. 1998 Jul;83(7):2479-85.
  105. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL. Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nat Med 2012;18: 413-421.
  106. Wright VC, Chang J, Jeng G, Macaluso M. Assisted reproductive technology surveillance–United States, 2005. MMWR Surveill Summ. 2008;57:1–23.
  107. Xiao J, Chang S, Chen S. The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2013 Dec;100(6):1594-601.e1-9.
  108. Yi YC, Chen MJ, Ho JY, Guu HF, Ho ES. Mitochondria transfer can enhance the murine embryo development. J Assist Reprod Genet. 2007;24:445-9.
  109. Zeng, H.-T., Ren, Z., Yeung, W.S., Shu, Y.M., Xu, Y.W., Zhuang, G.L., Liang, X.Y., 2007. Low mitochondrial DNA and ATP contents contribute to the absence of birefringent spindle imaged with PolScope in in-vitro matured human oocytes. Hum. Reprod. 22, 1681–1686.
  110. Zhang J, Chang L, Sone Y, Silber S. Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer. Reprod Biomed Online. 2010 Oct;21(4):485-9.
  111. Zhang J, Chang L, Sone Y, Silber S. Minimal ovarian stimulation (mini-IVF) for IVF utilizing vitrification and cryopreserved embryo transfer. Reprod Biomed Online. 2010 Oct;21(4):485-95.
Centro de Reprodução Humana do IPGO - Instituto Paulista de Ginecologia e Obstetrícia
Dr. Arnaldo Schizzi Cambiaghi & Equipe

Rua Abílio Soares, 1125 - Paraíso • CEP 04005 004 - São Paulo - SP • Tels.: (11) 3885-4333 / 3884-3218 • saude@ipgo.com.br

Caro leitor ou Jornalista

Aqui vocês encontrarão as últimas novidades, pesquisas e estudos na área de reprodução humana que poderão ser utilizadas para esclarecimentos pessoais ou no trabalho. Caso necessite de fotos, vídeos ou ilustrações, colocamo-nos a disposição através do Centro de Estudos do IPGO.

Conte conosco!

Fone: 55 (011) 3887-7764 / (011) 3057-1796 • saude@ipgo.com.br

As informações contidas neste site têm caráter informativo e educacional e, de nenhuma forma devem ser utilizadas para auto-diagnóstico, auto-tratamento e auto-medicação. Quando houver dúvidas, um médico deverá ser consultado. Somente ele está habilitado para praticar o ato médico, conforme recomendação do CONSELHO FEDERAL DE MEDICINA.